Transluminal angioplasty of the iliac and femoral arteries: follow-up results without anticoagulation.
With the advent of the angiographic balloon catheter, transluminal angioplasty has become a more effective procedure for the alleviation of symptoms of peripheral ischemia. In the past two and a half years we have performed this procedure on over 208 iliac and femoral arteries. One hundred twenty iliac arteries were dilated. Of these, 86% remained patent at one year and 83% at two years. Eighty-eight femoral arteries were dilated. Of these, 75% remained patent at one year and 67% at two years. These vessel survival rates are slightly less than those following surgery. However, the morbidity from transluminal angioplasty is very low and the mortality is essentially zero.
D000328:Adult; D000368:Aged; D000800:Angioplasty, Balloon; D000925:Anticoagulants / Q000627:therapeutic use*; D001241:Aspirin / Q000627:therapeutic use; D005260:Female; D005263:Femoral Artery; D005500:Follow-Up Studies; D006801:Humans; D007083:Iliac Artery; D007383:Intermittent Claudication / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D014655:Vascular Resistance; D014859:Warfarin / Q000627:therapeutic use
D000925:Anticoagulants; D014859:Warfarin; D001241:Aspirin